Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-66,200
Closed -$2M 4594
2025
Q4
$2M Buy
+66,200
New +$1.63M ﹤0.01% 3053
2025
Q1
Sell
-55,000
Closed -$1.54M 4307
2024
Q4
$1.54M Buy
+55,000
New +$1.47M ﹤0.01% 2921
2024
Q3
Sell
-119,600
Closed -$3.53M 4568
2024
Q2
$3.53M Sell
119,600
-130,900
-52% -$3.76M ﹤0.01% 2128
2024
Q1
$7.65M Buy
250,500
+91,300
+57% +$2.58M 0.01% 1566
2023
Q4
$3.73M Hold
159,200
﹤0.01% 2152
2023
Q3
$4.71M Buy
159,200
+109,900
+223% +$3.68M ﹤0.01% 1858
2023
Q2
$1.74M Buy
+49,300
New +$1.38M ﹤0.01% 2714
2023
Q1
Sell
-31,500
Closed -$701K 4484
2022
Q4
$701K Hold
31,500
﹤0.01% 3664
2022
Q3
$749K Buy
+31,500
New +$849K ﹤0.01% 3797

Other funds holding CFLT

David Shaw's CFLT Position: Q1 2026 in Review

David Shaw sold out of Confluent (CFLT) in Q1 2026, closing a stake of 2,957,770 shares — an estimated $89.4M sold.

David Shaw first reported a position in CFLT in Q3 2021 and held it in 14 quarters. The position peaked at $103M in Q3 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • David Shaw reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 2,957,770 Confluent shares in Q1 2026, an estimated $89.4M.
  • David Shaw first reported a position in Confluent in Q3 2021 and held it in 14 quarters.
  • David Shaw's Confluent position peaked at $103M in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.